MARATTO

article · New England Journal of Medicine

Evolving Epidemiology of Mpox in Africa in 2024

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

The high mpox disease burden in Africa, especially in the DRC - with a rising number of cases, high case fatality rate, and high degree of spread to other previously mpox-free African countries - is cause for increased international concern. Case detection, contact tracing, public health measures, and affordable vaccines are needed to implement interventions in the DRC to reduce the risk of global spread of the virus.

Research topics

  • Poxvirus research and outbreaks
  • Bacillus and Francisella bacterial research
  • Virology and Viral Diseases

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1056/nejmoa2411368

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.